Clinical Trials In Vasculitis: What's New, What's For You

Clinical Trials in Vasculitis: What's New, What's for You

vasculitisfoundation

New clinical trial looks at treatment option for rheumatoid arthritis

KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment

ANCA-Associated Vasculitis: What do the results of the RAVE trial mean? - John Stone

Researcher comment: The ADVOCATE trial | Peter Merkel

Medicine Matters rheumatology

What's Next? What's Ahead in Research?

vasculitisfoundation

Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis

ERA - European Renal Association

Diagnosing Severe Active ANCA-Associated Vasculitis: Importance of Clinical Assessment in GPA & MPA

KDIGO-ISN Webinar on What’s New in the Management and Treatment of GN: A look at ANCA and LN

GCA and Current Clinical Trials

vasculitisfoundation

International Vasculitis Research 2022

vasculitisfoundation

Vasculitis Research: What is on the horizon?

vasculitisfoundation

Dr. Peter A. Merkel of UPenn on Vasculitis Clinical Research Consortium (VCRC)

Medical breakthrough for those with rheumatoid arthritis

KENS 5: Your San Antonio News Source

KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines

ANCA: The Vasculitis Antibodies

Connected Rheumatology

CanVasc Consensus Recommendations for the Management of ANCA-associated Vasculitis: Arielle Mendel

The Journal of Rheumatology

Vasculitis Faculty Panel Q&A

Monitoring Patients With ANCA-Associated Vasculitis

Cleveland Clinic